Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 220

1.

Relationship between glucocorticoid receptor signal pathway and androgen-independent prostate cancer.

Yan TZ, Jin FS, Xie LP, Li LC.

Urol Int. 2008;81(2):228-33. doi: 10.1159/000144067. Epub 2008 Aug 29.

PMID:
18758226
2.

Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.

Culig Z, Bartsch G, Hobisch A.

Mol Cell Endocrinol. 2002 Nov 29;197(1-2):231-8. Review.

PMID:
12431817
3.

Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.

Yemelyanov A, Czwornog J, Gera L, Joshi S, Chatterton RT Jr, Budunova I.

Cancer Res. 2008 Jun 15;68(12):4763-73. doi: 10.1158/0008-5472.CAN-07-6104.

5.

Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation.

Seaton A, Scullin P, Maxwell PJ, Wilson C, Pettigrew J, Gallagher R, O'Sullivan JM, Johnston PG, Waugh DJ.

Carcinogenesis. 2008 Jun;29(6):1148-56. doi: 10.1093/carcin/bgn109. Epub 2008 May 16.

PMID:
18487223
6.

Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway .

Lou W, Ni Z, Dyer K, Tweardy DJ, Gao AC.

Prostate. 2000 Feb 15;42(3):239-42.

PMID:
10639195
7.

Expression and role of functional glucocorticoid receptors in the human androgen-independent prostate cancer cell line, DU145.

Dondi D, Maggi R, Scaccianoce E, Martini L, Motta M, Poletti A.

J Mol Endocrinol. 2001 Jun;26(3):185-91.

PMID:
11357055
9.

Interleukin-4 stimulates androgen-independent growth in LNCaP human prostate cancer cells.

Lee SO, Pinder E, Chun JY, Lou W, Sun M, Gao AC.

Prostate. 2008 Jan 1;68(1):85-91.

PMID:
18008330
10.

[Induction of apoptosis by mifepristone in androgen-independent prostate cancer cell lines in vitro].

Zhang H, Lü JJ, Gao QZ, Zhang J.

Zhonghua Wai Ke Za Zhi. 2006 Mar 15;44(6):382-5. Chinese.

PMID:
16638347
11.

Regulation of androgen receptor transactivity and mTOR-S6 kinase pathway by Rheb in prostate cancer cell proliferation.

Kobayashi T, Shimizu Y, Terada N, Yamasaki T, Nakamura E, Toda Y, Nishiyama H, Kamoto T, Ogawa O, Inoue T.

Prostate. 2010 Jun 1;70(8):866-74. doi: 10.1002/pros.21120.

PMID:
20127734
12.

Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations.

Shi Y, Chatterjee SJ, Brands FH, Shi SR, Pootrakul L, Taylor CR, Datar R, Cote RJ.

BJU Int. 2006 Jan;97(1):170-8.

13.
14.

Zoledronic acid effects interleukin-6 expression in hormone-independent prostate cancer cell lines.

Asbagh LA, Uzunoglu S, Cal C.

Int Braz J Urol. 2008 May-Jun;34(3):355-63; discussion 364.

15.

Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.

Ramberg H, Eide T, Krobert KA, Levy FO, Dizeyi N, Bjartell AS, Abrahamsson PA, Taskén KA.

Prostate. 2008 Jul 1;68(10):1133-42. doi: 10.1002/pros.20778.

PMID:
18454446
16.

Comparison of protein expression in two prostate cancer cell-lines, LNCaP and DU145, after treatment with somatostatin.

Liu Z, Marquez M, Nilsson S, Holmberg AR.

Oncol Rep. 2009 Dec;22(6):1451-8.

PMID:
19885599
17.

Regulation of interleukin-6-mediated PI3K activation and neuroendocrine differentiation by androgen signaling in prostate cancer LNCaP cells.

Xie S, Lin HK, Ni J, Yang L, Wang L, di Sant'Agnese PA, Chang C.

Prostate. 2004 Jun 15;60(1):61-7.

PMID:
15129430
18.

Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression.

Pang B, Zhang H, Wang J, Chen WZ, Li SH, Shi QG, Liang RX, Xie BX, Wu RQ, Qian XL, Yu L, Li QM, Huang CF, Zhou JG.

Prostate. 2009 Aug 1;69(11):1176-87. doi: 10.1002/pros.20969.

PMID:
19415690
19.

Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells.

Gravina GL, Festuccia C, Millimaggi D, Dolo V, Tombolini V, de Vito M, Vicentini C, Bologna M.

Prostate. 2008 May 15;68(7):793-801. doi: 10.1002/pros.20748.

PMID:
18324645
20.

Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor.

Malinowska K, Neuwirt H, Cavarretta IT, Bektic J, Steiner H, Dietrich H, Moser PL, Fuchs D, Hobisch A, Culig Z.

Endocr Relat Cancer. 2009 Mar;16(1):155-69. doi: 10.1677/ERC-08-0174. Epub 2008 Nov 14.

Supplemental Content

Support Center